Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00374699
Status:
COMPLETED
Last Update Posted:
2009-10-14
First Post:
2006-09-07
Brief Title:
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer NKT Cell Lymphomas
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Organization Data
Organization:
Samsung Medical Center
Class:
OTHER
Study ID:
2005-07-021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Samsung Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
CISL Consortium for Improving Survival of Lymphoma
Old Organization:
CISL Consortium for Improving Survival of Lymphoma
Collaborators
| Name | Class |
|---|---|
| Janssen Medical Affairs | INDUSTRY |